Bitte verwenden Sie diesen Link, um diese Publikation zu zitieren, oder auf sie als Internetquelle zu verweisen: https://hdl.handle.net/10419/316995 
Autor:innen: 
Erscheinungsjahr: 
2025
Schriftenreihe/Nr.: 
ETLA Working Papers No. 123
Versionsangabe: 
This Version: 15.4.2025 - First published: 31.12.2024
Verlag: 
The Research Institute of the Finnish Economy (ETLA), Helsinki
Zusammenfassung: 
I study the passthrough of regulated ad valorem pharmacy markups and reduced Value Added Tax (VAT) rates to pharmaceutical retail prices in Finland. My reduced form evidence shows that pharmaceutical manufacturers respond to a decrease in regulated pharmacy markups by increasing their wholesale prices. I estimate a structural model of pharmaceutical supply and demand using data from the Finnish statin market. My results show that manufacturers benefit significantly from existing pharmaceutical tax subsidies, making them an expensive way to support poorer patients.
Schlagwörter: 
Pharmaceuticals
Passthrough
Price regulation
Commodity taxation
Market power
JEL: 
I11
H22
H25
H51
L51
C23
Dokumentart: 
Working Paper

Datei(en):
Datei
Größe
743.44 kB





Publikationen in EconStor sind urheberrechtlich geschützt.